Theo J.M. Helmerhorst

Author

Also Known As

T Helmerhorst, T J Helmerhorst, T J M Helmerhorst, T. J. M. Helmerhorst, T.J.M. Helmerhorst, THEO J.M. HELMERHORST, Theo Helmerhorst, Theo J M Helmerhorst, Theo J. Helmerhorst, Theo J. M. Helmerhorst

102

Publications

7.2K

Citations

H-Index

Concepts

All Affiliations

Erasmus MC Erasmus University Rotterdam Amsterdam UMC Location Vrije Universiteit Amsterdam The Netherlands Cancer Institute University of Amsterdam

About

Theo J.M. Helmerhorst is an author at Erasmus MC specializing in medicine, cervical cancer, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	25	2.6K
2	Public Health	15	15	2.1K
3	Cell Biology	5	5	301
4	Endocrinology	3	3	278
5	Anatomy	1	1	57

Theo J.M. Helmerhorst

Publications

6.4K

Citations

H-Index

Page 1

	Year	Citations
Relation of human papilloma virus status to cervical lesions and consequences for cervical-cancer screening: a prospective study Marielle Nobbenhuis, Jan M.M. Walboomers, Theo J.M. Helmerhorst, The Lancet EpidemiologyCervical Cancer ManagementCervical CancerCervical HealthHuman Papillomavirus Vaccines	1999	702
Treatment of Vulvar Intraepithelial Neoplasia with Topical Imiquimod Manon van Seters, Marc van Beurden, Fiebo J.W. ten Kate, New England Journal of Medicine	2008	389
The presence of persistent high‐risk hpv genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months Ans J. Remmink, Jan M.M. Walboomers, Theo J.M. Helmerhorst, International Journal of Cancer	1995	373
Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age‐dependent Peter Melkert, Adriaan J. C. van den Brule, Elle K.J. Risse, International Journal of Cancer	1993	288
Human papillomavirus 16 load in normal and abnormal cervical scrapes: An indicator of CIN II/III and viral clearance Mark van Duin, Peter J.F. Snijders, Henri F.J. Schrijnemakers, International Journal of Cancer PathologyGynecologyCytopathologyCancer-associated VirusHuman Papillomavirus Vaccines	2002	258
Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study Mariëlle Kocken, Theo J.M. Helmerhorst, Johannes Berkhof, The Lancet Oncology Cervical Cancer ManagementCervical Cancer ScreeningCervical CancerCervical HealthPrecancerous Lesions	2011	243
Estrogen Receptor Polymorphism Predicts the Onset of Natural and Surgical Menopause<sup>1</sup> A. Weel, André G. Uitterlinden, I. C. D. Westendorp, The Journal of Clinical Endocrinology & Metabolism Hormonal ContraceptiveGeneticsGenetic EpidemiologyReproductive HealthGynecology	1999	224
Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia Marielle Nobbenhuis, C. J. L. M. Meijer, Adriaan J. C. van den Brule, British Journal of Cancer	2001	204
Human papillomavirus testing on self‐sampled cervicovaginal brushes: An effective alternative to protect nonresponders in cervical screening programs Aagje G. Bais, Folkert J. van Kemenade, Johannes Berkhof, International Journal of Cancer	2007	174
An Autoimmune Phenotype in Vulvar Lichen Sclerosus and Lichen Planus: A Th1 Response and High Levels of MicroRNA-155 Annelinde Terlou, Lindy A.M. Santegoets, W I van der Meijden, Journal of Investigative Dermatology	2011	173

Page 1